Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BOPA 2023 | Optimizing treatment protocols for young adult patients with cancer

Vanessa McLelland, University Hospitals Bristol & Weston NHS Foundation Trust, Bristol, UK, discusses benefits of administering pediatric treatment plans to young adult patients. As demonstrated in the Phase III UKALL 2011 trial (EudraCT 2010-020923-22), young adult patients fared better when given pediatric protocols. Recruitment of young adult patients in this setting additionally benefits trial organizers, where more reliable data can be obtained upon enrolment of young adult patients. This interview took place at the 26th Annual British Oncology Pharmacy Association (BOPA) Symposium in Newport, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.